Skip to content
Curevo VaccineCurevo Vaccine
  • About
    • About Us
    • Management Team
  • Programs
    • Amezosvatein for Shingles
    • Amezosvatein for Chickenpox
  • Contact Us

Category: News

Curevo history 450x249
11 Feb, 2022
News

Vaccine startup Curevo takes on pharma giant GSK, raises $60M for trial of shingles shot

by curevovaccine
60 Million Funding Supports Shingles Vaccine Candidate 1200 x 800
11 Feb, 2022
News, Vaccines

$60 Million Funding Supports Shingles Vaccine Candidate

by curevovaccine
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines 658x324
10 Feb, 2022
News, Press Releases, Vaccines

Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines

by curevovaccine
George-Simeon 2048 x 1152
10 Feb, 2022
News, Vaccines

A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster. RA Capital is on board

by curevovaccine
Shingles Vaccine by Curevo 4480 x 6720
18 Mar, 2021
News, Press Releases, Vaccines

SAHPRA Approval Press Announcement 2021

by curevovaccine
Shingle and Varicella vaccines at Curevo 6000x4000
15 Sep, 2020
News, Vaccines

Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101

by curevovaccine
Vaccines 1626 x 1080
26 Sep, 2019
News, Press Releases, Vaccines

Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101

by curevovaccine
GC Pharma to Establish Curevo 1080x1080
18 May, 2018
News, Vaccines

GC Pharma to Establish Curevo

by curevovaccine

Recent Posts

  • Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention May 26, 2026
  • Curevo Enrolls First Participants in Phase 2 Extension Trial June 2, 2025
  • Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine March 17, 2025
  • Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine January 12, 2025

Categories

  • Events2
  • News8
  • Press Releases16
  • Vaccines8

Tags

  • adjuvanted vaccine
  • biotechnology company
  • clinical studies
  • CMO
  • CRV-101
  • Guy De La Rosa
  • infectious disease
  • investigational vaccine
  • JMP24
  • Scientific research
  • SHINGLES
  • Shingles Vaccine
  • Shingrix
  • subunit vaccines
  • VACCINE
  • varicella zoster virus
Curevo Vaccine logo white 158x90

___________________

A wholly owned subsidiary of Eli Lilly and Company

Curevo Inc.
18911 N Creek Pkwy #150
Bothell, WA 98011

+1.206.492.5722

Terms of Use
Privacy Policy
Cookie Policy

Consumer Health Privacy Notice

 © 2026 Curevo Inc.® All rights reserved.

Loading Comments...